Trial intelligence / Profile preview

Safety and Efficacy of Clobetasol Propionate Foam vs Lotion in Plaque-Type Psoriasis

NCT00852761Phase 4Completed

Sponsor
GSK
Start
Mar 2009
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of clobetasol in plaque psoriasis (2 arms), sponsored by GSK. Primary endpoint: At Least a One Grade Improvement for the Target Psoriasis Lesion on the Elbow or Knee (Psoriasis Grading Scale) at Day 15. Started Mar 2009; status: completed.

02

Drugs

clobetasol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT00852761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00852761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call